Dexlansoprazole Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (30 mg,and 60 mg); Applications (Gastroesophageal Reflux Disease, and Heal Erosive Esophagitis)

Report Code: TIPRE00020514 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

The pH level in the human digestive system needs to be maintained with the desired limit. The acidity level is elevated due to various factors such as the intake of spicy food, a side effect of medication, and others. Rabeprazole is available in different doses. It helps reduce stomach acid and is used to treat indications such as gastroesophageal reflux disease, duodenal ulcers and used in combination with antibiotics to treat bacterial infections in the stomach.

MARKET DYNAMICS

The Dexlansoprazole market is driving due to the fast food, stress, and intake of alcohol and aerated drinks, and rise in prevalence of gastroesophageal reflux disease. However, pipeline product with market player is expected to hamper the growth of the global rabeprazole market.

MARKET SCOPE

The "Dexlansoprazole Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of dexlansoprazole market with detailed market segmentation by type and application. The dexlansoprazole market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in dexlansoprazole market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The dexlansoprazole market is segmented on the basis of type and application. Based on type, the market is segmented as 30 mg and 60 mg. On the basis of application, the market is categorized as gastroesophageal reflux disease and heal erosive esophagitis.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Dexlansoprazole market based on various segments. It also provides market size and forecast estimates from year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Dexlansoprazole market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Dexlansoprazole market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Dexlansoprazole market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Dexlansoprazole market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Dexlansoprazole market are anticipated to have lucrative growth opportunities in the future with the rising demand for Dexlansoprazole in the global market. Below mentioned is the list of few companies engaged in the Dexlansoprazole market.

The report also includes the profiles of key players in Dexlansoprazole market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Takeda
  •   Cardinal Health
  •   Suzhou Homesun Pharmaceutical
  •   Frontida
  •   Zhendong Group
  •   Ouya Pharmaceutical
  •   Heron Pharmaceutical
  •   Sailong

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Dexlansoprazole Market - By Type
1.3.2 Dexlansoprazole Market - By Applications
1.3.3 Dexlansoprazole Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. DEXLANSOPRAZOLE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DEXLANSOPRAZOLE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. DEXLANSOPRAZOLE MARKET - GLOBAL MARKET ANALYSIS
6.1. DEXLANSOPRAZOLE - GLOBAL MARKET OVERVIEW
6.2. DEXLANSOPRAZOLE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. DEXLANSOPRAZOLE MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. 30 MG
7.3.1. Overview
7.3.2. 30 mg Market Forecast and Analysis
7.4. 60 MG
7.4.1. Overview
7.4.2. 60 mg Market Forecast and Analysis
8. DEXLANSOPRAZOLE MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATIONS
8.1. OVERVIEW
8.2. APPLICATIONS MARKET FORECASTS AND ANALYSIS
8.3. GASTROESOPHAGEAL REFLUX DISEASE
8.3.1. Overview
8.3.2. Gastroesophageal Reflux Disease Market Forecast and Analysis
8.4. HEAL EROSIVE ESOPHAGITIS
8.4.1. Overview
8.4.2. Heal Erosive Esophagitis Market Forecast and Analysis
9. DEXLANSOPRAZOLE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Dexlansoprazole Market Overview
9.1.2 North America Dexlansoprazole Market Forecasts and Analysis
9.1.3 North America Dexlansoprazole Market Forecasts and Analysis - By Type
9.1.4 North America Dexlansoprazole Market Forecasts and Analysis - By Applications
9.1.5 North America Dexlansoprazole Market Forecasts and Analysis - By Countries
9.1.5.1 United States Dexlansoprazole Market
9.1.5.1.1 United States Dexlansoprazole Market by Type
9.1.5.1.2 United States Dexlansoprazole Market by Applications
9.1.5.2 Canada Dexlansoprazole Market
9.1.5.2.1 Canada Dexlansoprazole Market by Type
9.1.5.2.2 Canada Dexlansoprazole Market by Applications
9.1.5.3 Mexico Dexlansoprazole Market
9.1.5.3.1 Mexico Dexlansoprazole Market by Type
9.1.5.3.2 Mexico Dexlansoprazole Market by Applications
9.2. EUROPE
9.2.1 Europe Dexlansoprazole Market Overview
9.2.2 Europe Dexlansoprazole Market Forecasts and Analysis
9.2.3 Europe Dexlansoprazole Market Forecasts and Analysis - By Type
9.2.4 Europe Dexlansoprazole Market Forecasts and Analysis - By Applications
9.2.5 Europe Dexlansoprazole Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Dexlansoprazole Market
9.2.5.1.1 Germany Dexlansoprazole Market by Type
9.2.5.1.2 Germany Dexlansoprazole Market by Applications
9.2.5.2 France Dexlansoprazole Market
9.2.5.2.1 France Dexlansoprazole Market by Type
9.2.5.2.2 France Dexlansoprazole Market by Applications
9.2.5.3 Italy Dexlansoprazole Market
9.2.5.3.1 Italy Dexlansoprazole Market by Type
9.2.5.3.2 Italy Dexlansoprazole Market by Applications
9.2.5.4 Spain Dexlansoprazole Market
9.2.5.4.1 Spain Dexlansoprazole Market by Type
9.2.5.4.2 Spain Dexlansoprazole Market by Applications
9.2.5.5 United Kingdom Dexlansoprazole Market
9.2.5.5.1 United Kingdom Dexlansoprazole Market by Type
9.2.5.5.2 United Kingdom Dexlansoprazole Market by Applications
9.2.5.6 Rest of Europe Dexlansoprazole Market
9.2.5.6.1 Rest of Europe Dexlansoprazole Market by Type
9.2.5.6.2 Rest of Europe Dexlansoprazole Market by Applications
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Dexlansoprazole Market Overview
9.3.2 Asia-Pacific Dexlansoprazole Market Forecasts and Analysis
9.3.3 Asia-Pacific Dexlansoprazole Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Dexlansoprazole Market Forecasts and Analysis - By Applications
9.3.5 Asia-Pacific Dexlansoprazole Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Dexlansoprazole Market
9.3.5.1.1 Australia Dexlansoprazole Market by Type
9.3.5.1.2 Australia Dexlansoprazole Market by Applications
9.3.5.2 China Dexlansoprazole Market
9.3.5.2.1 China Dexlansoprazole Market by Type
9.3.5.2.2 China Dexlansoprazole Market by Applications
9.3.5.3 India Dexlansoprazole Market
9.3.5.3.1 India Dexlansoprazole Market by Type
9.3.5.3.2 India Dexlansoprazole Market by Applications
9.3.5.4 Japan Dexlansoprazole Market
9.3.5.4.1 Japan Dexlansoprazole Market by Type
9.3.5.4.2 Japan Dexlansoprazole Market by Applications
9.3.5.5 South Korea Dexlansoprazole Market
9.3.5.5.1 South Korea Dexlansoprazole Market by Type
9.3.5.5.2 South Korea Dexlansoprazole Market by Applications
9.3.5.6 Rest of Asia-Pacific Dexlansoprazole Market
9.3.5.6.1 Rest of Asia-Pacific Dexlansoprazole Market by Type
9.3.5.6.2 Rest of Asia-Pacific Dexlansoprazole Market by Applications
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Dexlansoprazole Market Overview
9.4.2 Middle East and Africa Dexlansoprazole Market Forecasts and Analysis
9.4.3 Middle East and Africa Dexlansoprazole Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Dexlansoprazole Market Forecasts and Analysis - By Applications
9.4.5 Middle East and Africa Dexlansoprazole Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Dexlansoprazole Market
9.4.5.1.1 South Africa Dexlansoprazole Market by Type
9.4.5.1.2 South Africa Dexlansoprazole Market by Applications
9.4.5.2 Saudi Arabia Dexlansoprazole Market
9.4.5.2.1 Saudi Arabia Dexlansoprazole Market by Type
9.4.5.2.2 Saudi Arabia Dexlansoprazole Market by Applications
9.4.5.3 U.A.E Dexlansoprazole Market
9.4.5.3.1 U.A.E Dexlansoprazole Market by Type
9.4.5.3.2 U.A.E Dexlansoprazole Market by Applications
9.4.5.4 Rest of Middle East and Africa Dexlansoprazole Market
9.4.5.4.1 Rest of Middle East and Africa Dexlansoprazole Market by Type
9.4.5.4.2 Rest of Middle East and Africa Dexlansoprazole Market by Applications
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Dexlansoprazole Market Overview
9.5.2 South and Central America Dexlansoprazole Market Forecasts and Analysis
9.5.3 South and Central America Dexlansoprazole Market Forecasts and Analysis - By Type
9.5.4 South and Central America Dexlansoprazole Market Forecasts and Analysis - By Applications
9.5.5 South and Central America Dexlansoprazole Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Dexlansoprazole Market
9.5.5.1.1 Brazil Dexlansoprazole Market by Type
9.5.5.1.2 Brazil Dexlansoprazole Market by Applications
9.5.5.2 Argentina Dexlansoprazole Market
9.5.5.2.1 Argentina Dexlansoprazole Market by Type
9.5.5.2.2 Argentina Dexlansoprazole Market by Applications
9.5.5.3 Rest of South and Central America Dexlansoprazole Market
9.5.5.3.1 Rest of South and Central America Dexlansoprazole Market by Type
9.5.5.3.2 Rest of South and Central America Dexlansoprazole Market by Applications
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL DEXLANSOPRAZOLE MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. DEXLANSOPRAZOLE MARKET, KEY COMPANY PROFILES
12.1. TAKEDA
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. CARDINAL HEALTH
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. SUZHOU HOMESUN PHARMACEUTICAL
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. FRONTIDA
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ZHENDONG GROUP
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. OUYA PHARMACEUTICAL
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. HERON PHARMACEUTICAL
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SAILONG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Takeda
2. Cardinal Health
3. Suzhou Homesun Pharmaceutical
4. Frontida
5. Zhendong Group
6. Ouya Pharmaceutical
7. Heron Pharmaceutical
8. Sailong
TIPRE00020514
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking